Bakterie Modyfikowane Genetycznie – Perspektywy Zastosowania w Profilaktyce, Diagnostyce I Terapii

Macura, Barbara; Kiecka, Aneta; Szczepanik, Marian

doi:10.2478/am-2022.0003

Abstract

The microbiota plays an important role in human health. Disturbance in microbiota composition can be compensated by administration of probiotic microorganisms. However, their application is associated with some constraints. Probiotics are commonly used in disease prevention, whereas they play only a supportive role in disease therapy. Moreover, probiotics during technological processes and gastrointestinal tract passage may lose their beneficial properties. These constraints can be overcome by genetic modification of bacteria. The current research shows that genetically modified bacteria can have new biological properties and can be used in diagnostics and therapy.

References

Aggarwal N., Breedon A.M.E., Davis C.M., Hwang I.Y., Chang M.W.: Engineering probiotics for therapeutic applications: recent examples and translational outlook. Curr. Opin. Biotechnol. 65, 171–179, doi: 10.1016/j.copbio.2020.02.016 (2020)
Open DOI Search in Google Scholar Back to article
Akdis C.A.: Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat. Rev. Immunol. doi: 10.1038/s41577-021-00538-7 (2021)
Open DOI Search in Google Scholar Back to article
Andrade J.C., Almeida D., Domingos M., Seabra C.L., Machado D., Freitas A.C., Gomes A.M.: Commensal obligate anaerobic bacteria and health: production, storage, and delivery strategies. Front. Bioeng. Biotechnol. 8, doi:10.3389/fbioe.2020.00550 (2020)
Open DOI Search in Google Scholar Back to article
Bae H.R., Leung P.S.C., Hodge D.L., Fenimore J.M., Jeon S.M., Thovarai V., Dzutsev A., Welcher A.A., Boedigheimer M., Damore M.A., Choi M.S., Fravell R.A. Trinchieri G., Gershwin M.E., Young H.A.: Multi-omics: differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases. J. Autoimmun. 111, 102436, doi: 10.1016/j.jaut.2020.102436 (2020)
Open DOI Search in Google Scholar Back to article
Barra M., Danino T., Garrido D.: Engineered probiotics for detection and treatment of inflammatory intestinal diseases. Front. Bioeng. Biotechnol. 8, 265, doi: 10.3389/fbioe.2020.00265 (2020)
Open DOI Search in Google Scholar Back to article
Barrientos-Durán A., Fuentes-López A., de Salazar A., Plaza-Díaz J., García F.: Reviewing the composition of vaginal microbiota: inclusion of nutrition and probiotic factors in the maintenance of eubiosis. Nutrients, 12, 419, https://doi.org/10.3390/nu12020419 (2020)
Search in Google Scholar Back to article
Bezkorovainy A.: Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73, 399–405, https://doi.org/10.1093/ajcn/73.2.399s (2001)
Search in Google Scholar Back to article
Brüssow H.: Problems with the concept of gut microbiota dysbiosis. Microb. Biotechnol. 13, 423–434, doi:10.1111/1751-7915.13479 (2020)
Open DOI Search in Google Scholar Back to article
Chang C.J., Lin T.L., Tsai Y.L., Wu T.R., Lai W.F., Lu C.C., Lai H.C.: Next generation probiotics in disease amelioration. J. Food Drug Anal. 27, 615–622, doi: 10.1016/j.jfda.2018.12.011 (2019)
Open DOI Search in Google Scholar Back to article
Corcoran B.M., Ross R.P., Fitzgerald G.F., Dockery P., Stanton C.: Enhanced survival of GroESL-overproducing Lactobacillus paracasei NFBC 338 under stressful conditions induced by drying. Appl. Environ. Microbiol. 72, 5104–7, doi: 10.1128/AEM.02626-05 (2006)
Open DOI Search in Google Scholar Back to article
Da Silva T.F., Casarotti S.N., de Oliveira G.L.V., Penna A.L.B.: The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts. Crit. Rev. Food Sci. Nutr. 61, 337–355, doi: 10.1080/10408398.2020.1733483 (2021)
Open DOI Search in Google Scholar Back to article
Duong M.T., Qin Y., You S.H., Min J.J.: Bacteria-cancer interactions: bacteria-based cancer therapy. Exp. Mol. Med. 51, 12, 1–15, doi: 10.1038/s12276-019-0297-0 (2019)
Open DOI Search in Google Scholar Back to article
Eun-Sook L., Eun-Ji S., Young-Do N., So-Young L.: Probiotics in human health and disease: from nutribiotics to pharmabiotics. J. Microbiol. 56, 773–782 doi: 10.1007/s12275-018-8293-y (2018)
Open DOI Search in Google Scholar Back to article
Ferreira A.K., Mambelli L.I., Pillai S.Y.: Intervening in disease through genetically-modified bacteria. Best Pract. Res. Clin. Gastroenterol. 31, 693–697 (2017)
Search in Google Scholar Back to article
Gałecka M., Basińska A. M., Bartnicka A. Probiotyki – implikacje w praktyce lekarza rodzinnego. Forum Med. Rodz. 12, 170–182 (2018)
Search in Google Scholar Back to article
Gardiner G.E., O’Sullivan E., Kelly J., Auty M.A., Fitzgerald G.F., Collins J.K., Ross R.P., Stanton C.: Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying. Appl. Environ. Microbiol. 66, 2605–2612, doi: 10.1128/aem.66.6.2605-2612.2000 (2000)
Open DOI Search in Google Scholar Back to article
Giron F., Quigley E.M.M.: Pharmabiotic manipulation of the microbiota in gastrointestinal disorders: a clinical perspective. J. Neurogastroenterol. Motil. 24, 355–366, doi: 10.5056/jnm18004 (2018)
Open DOI Search in Google Scholar Back to article
Hwang I.Y., Koh E., Wong A., March J.C., Bentley W.E., Lee Y.S., Chang M.W. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nat. Commun. 8, 15028 doi: 10.1038/ncomms15028 (2017)
Open DOI Search in Google Scholar Back to article
Jach M., Łoś R., Maj M., Malm A.: Probiotyki – aspekty funkcjonalne i technologiczne. Post. Mikrobiol. 52, 161–170 (2013)
Search in Google Scholar Back to article
Kali A.: Human microbiome engineering: the future and beyond. J. Clin. Diagn. Res. 9, DE01-4, doi: 10.7860/JCDR/2015/14946.6570 (2015)
Open DOI Search in Google Scholar Back to article
Kang M., Choe D., Kim K., Cho B.K., Cho S.: Synthetic biology approaches in the development of engineered therapeutic microbes. Int. J. Mol. Sci. 21, 8744, doi: 10.3390/ijms21228744 (2020)
Open DOI Search in Google Scholar Back to article
Kramer M.G., Masner M., Ferreira F.A., Hoffman R.M.: Bacterial therapy of cancer: promises, limitations and insights for future directions. Front. Microbiol. 9, 16 doi: 10.3389/fmicb.2018.00016 (2018)
Open DOI Search in Google Scholar Back to article
Kumar M., Yadav A.K., Verma V., Singh B., Mal G., Nagpal R., Hemalatha R.: Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects. Future Microbiol. 11, 585–600 doi: 10.2217/fmb.16.4. (2016)
Open DOI Search in Google Scholar Back to article
Landry B.P., Tabor J.J. Engineering diagnostic and therapeutic gut bacteria. Microbiol. Spectr. 5, doi: 10.1128/microbiolspec.BAD-0020-2017 (2017)
Open DOI Search in Google Scholar Back to article
Lee J.W., Chan C.T.Y., Slomovic S., Collins J.J. Next-generation biocontainment systems for engineered organisms. Nat. Chem. Biol. 14, 530–537, doi: 10.1038/s41589-018-0056-x (2018)
Open DOI Search in Google Scholar Back to article
Lim D., Song M.: Development of bacteria as diagnostics and therapeutics by genetic engineering. J. Microbiol. 57, 637–643, doi: 10.1007/s12275-019-9105-8 (2019)
Open DOI Search in Google Scholar Back to article
Mazhar S.F., Afzal M., Almatroudi A., Munir S., Ashfaq U.A., Rasool M., Raza H., Munir H.M.W., Rajoka M.S.R., Khurshid M.: The prospects for the therapeutic implications of genetically engineered probiotics. J. Food Qual. article ID 9676452 https://doi.org/10.1155/2020/9676452 (2020)
Search in Google Scholar Back to article
Moloko G.M., Mapitsi S.T.: Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. Gut Pathog. 9, 28, doi: 10.1186/s13099-017-0178-9 (2017)
Open DOI Search in Google Scholar Back to article
Mroczyńska M., Libudzisz Z., Gałęcka M., Szachta P.: Mikroorganizmy jelitowe człowieka i ich aktywność metaboliczna. Prz. Gastroenterol. 4, 218–224 (2016)
Search in Google Scholar Back to article
Ozdemir T., Fedorec A.J.H., Danino T., Barnes C.P.: Synthetic biology and engineered live biotherapeutics: toward increasing system complexity. Cell Syst. 7, 5–16, doi: 10.1016/j.cels.2018.06.008 (2018)
Open DOI Search in Google Scholar Back to article
Paton A.W, Morona R., Paton J.C. Bioengineered microbes in disease therapy. Trends Mol. Med. 18, 417–425, doi: 10.1016/j.molmed.2012.05.006 (2012)
Open DOI Search in Google Scholar Back to article
Pedrolli D.B., Ribeiro N.V., Squizato P.N., de Jesus V.N., Cozetto D.A: Team AQA Unesp at iGEM 2017. Engineering microbial living therapeutics: the synthetic biology toolbox. Trends Biotechnol. 37, 100–115, doi: 10.1016/j.tibtech.2018.09.005 (2019)
Open DOI Search in Google Scholar Back to article
Plavec T.V., Berlec A.: Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides. Appl. Microbiol. Biotechnol. 103, 2053–2066, doi: 10.1007/s00253-019-09628-y (2019)
Open DOI Search in Google Scholar Back to article
Pongking T., Haonon O., Dangtakot R., Onsurathum S., Jusakul A., Intuyod K., Sangka A., Anutrakulchai S., Cha’on U., Pinlaor S., Pinlaor P.: A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. PLoS One, 15, 4, e0231237, doi:10.1371/journal.pone.0231237 (2020)
Open DOI Search in Google Scholar Back to article
Ropot A.V., Karamzin A.M., Sergeyev O.V.: Cultivation of the next-generation probiotic akkermansia muciniphila, methods of its safe delivery to the intestine, and factors contributing to its growth in vivo. Curr. Microbiol. 77, 8, 1363–1372, doi: 10.1007/s00284-020-01992-7 (2020)
Open DOI Search in Google Scholar Back to article
Rottinghaus A.G., Amrofell M.B., Moon T.S.: Biosensing in smart engineered probiotics. Biotechnol. J. 15, e1900319, doi: 10.1002/biot.201900319 (2020)
Open DOI Search in Google Scholar Back to article
Ruszkowski J., Szewczyk A., Witkowski J. M.: Przegląd doustnych prebiotyków, probiotyków, synbiotyków i postbiotyków dostępnych na polskim rynku aptecznym. Farm. Pol. 74, 2, 114–122 (2018)
Search in Google Scholar Back to article
Sharma R., Gupta D., Mehrotra R., Mago P.: Psychobiotics: the next-generation probiotics for the brain. Curr. Microbiol. 78, 2, 449–463, doi: 10.1007/s00284-020-02289-5 (2021)
Open DOI Search in Google Scholar Back to article
Sheehan V.M., Sleator R.D., Fitzgerald G.F., Hill C.: Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl. Environ. Microbiol. 72, 3, 2170–2177, doi: 10.1128/AEM.72.3.2170-2177.2006 (2006)
Open DOI Search in Google Scholar Back to article
Skrzydło-Radomańska B., Wronecki J.: Czy mikrobiotę jelitową można skutecznie modyfikować? Varia Medica, 3, 1, 18–26 (2019)
Search in Google Scholar Back to article
Sleator R.D., Hill C.: Rational design of improved pharmabiotics. J. Biomed. Biotechnol. 275287, doi: 10.1155/2009/275287 (2009)
Open DOI Search in Google Scholar Back to article
Sola-Oladokun B., Culligan E.P., Sleator R.D.: Engineered probiotics: applications and biological containment. Annu. Rev. Food Sci. Technol. 28, 8, 353–370, doi: 10.1146/annurev-food-030216-030256 (2017)
Open DOI Search in Google Scholar Back to article
Tan Y., Shen J., Si T., Ho C.L., Yinqing Li Y., Dai L.: Engineered live biotherapeutics: progress and challenges. Review Biotechnol. J. 15, 10, e2000155, doi: 10.1002/biot.202000155 (2020)
Open DOI Search in Google Scholar Back to article
Thursby E., Juge N.: Introduction to the human gut microbiota. Biochem. J. 474, 1823–1836, doi: https://doi.org/10.1042/BCJ20160510 (2017)
Search in Google Scholar Back to article
Tyagi P., Tasleem M., Prakash S., Chouhan G.: Intermingling of gut microbiota with brain: exploring the role of probiotics in battle against depressive disorders. Food Res. Int. 137, 109489, doi: 10.1016/j.foodres.2020.109489 (2020)
Open DOI Search in Google Scholar Back to article
Vallianou N., Stratigou T., Christodoulatos G.S., Tsigalou C., Dalamaga M.: Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives. Curr. Obes. Rep. 9, 179–192, https://doi.org/10.1007/s13679-020-00379-w (2020)
Search in Google Scholar Back to article
Vandenplas Y., Huys G., Daube G.: Probiotics: an update. J. Pediatr. (Rio J.), 91, 6–21, doi: 10.1016/j.jped.2014.08.005. Epub 2014 Oct 23. (2015)
Open DOI Search in Google Scholar Back to article
Wieërs G., Belkhir L., Enaud R., Leclercq S., Philippart de Foy J.M., Dequenne I., de Timary P., Cani P.D.: How probiotics affect the microbiota. Front. Cell Infect. Microbiol. 9, 454, doi:10.3389/fcimb.2019.00454 (2020)
Open DOI Search in Google Scholar Back to article
Wilkins L.J., Monga M., Miller A.W.: Defining dysbiosis for a cluster of chronic diseases. Sci. Rep. 9, 12918, doi:10.1038/s41598-019-49452-y (2019)
Open DOI Search in Google Scholar Back to article
Wu C., Huang J., Zhou R.: Genomics of lactic acid bacteria: current status and potential applications. Crit. Rev. Microbiol. 43, 393–404, doi: 10.1080/1040841X.2016.1179623 (2017)
Open DOI Search in Google Scholar Back to article
Yadav R., Kumar V., Baweja M., Shukla P.: Gene editing and genetic engineering approaches for advanced probiotics: a review. Crit. Rev. Food Sci. Nutr. 58, 1735–1746, doi: 10.1080/10408398.2016.1274877 (2018)
Open DOI Search in Google Scholar Back to article
Yadav M., Shukla P.: Efficient engineered probiotics using synthetic biology approaches: a review. Biotechnol. Appl. Biochem. 67, 22–29, doi: 10.1002/bab.1822 (2020)
Open DOI Search in Google Scholar Back to article
Yadav M., Shukla P.: Recent systems biology approaches for probiotics use in health aspects: a review. 3 Biotech. 9, 448, doi: 10.1007/s13205-019-1980-5 (2019)
Open DOI Search in Google Scholar Back to article
Yao M., Xie J., Du H., McClements D.J., Xiao H., Li L.: Progress in microencapsulation of probiotics: a review. Compr. Rev. Food Sci. Food Saf. 19, 2, 857–874, doi: 10.1111/1541-4337.12532 (2020)
Open DOI Search in Google Scholar Back to article
Zhou Z., Chen X., Sheng H., Shen X., Sun X., Yan Y., Wang J., Yuan Q.: Engineering probiotics as living diagnostics and therapeutics for improving human health. Microb. Cell Fact. 19, 56, doi: 10.1186/s12934-020-01318-z (2020)
Open DOI Search in Google Scholar Back to article
Zou Y., Chen T.: Engineered akkermansia muciniphila: a promising agent against diseases. Exp. Ther. Med. 20, 285, doi: 10.3892/etm.2020.9415 (2020)
Open DOI Search in Google Scholar Back to article
Zuo F., Chen S., Marcotte H.: Engineer probiotic bifidobacteria for food and biomedical applications – current status and future prospective. Review Biotechnol. Adv. 45, 107654, doi: 10.1016/j.biotechadv.2020.107654 (2020)
Open DOI Search in Google Scholar Back to article

Bakterie Modyfikowane Genetycznie – Perspektywy Zastosowania w Profilaktyce, Diagnostyce I Terapii

Abstract

Paradigm

My account